Overview

1. Executive Summary (Confidence: High)

Operating as a public-private partnership with a statutory mandate from the Swiss federal government, Switzerland Innovation is the primary vehicle for maintaining Switzerland’s global leadership in R&D.[28] The network comprises six legally independent locations (Park Basel Area, Park Zurich, Park West EPFL, Park Ost, Park Innovaare, and Park Biel/Bienne) spanning 16 total sites across the country.[29] By hosting over 700 resident companies and 68 research partners, the innovation parks facilitate the rapid transfer of academic findings into marketable products.[28] The platform is particularly strong in the Life Sciences and Digital Health sectors, offering specialized biotech infrastructure and a vibrant community that attracts both early-stage spin-offs (like T3 Pharma) and global giants (like BD and J&J).[29]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.